HR 7867·Federal·house
Infant Formula Safety Modernization Act of 2026
In CommitteeFiled Mar 9, 2026
Sponsor: Rep. DeLauro, Rosa L. [D-CT-3] (D)
Latest Action
Referred to the House Committee on Energy and Commerce.
Mar 9, 2026
Summary
The bill amends the Federal Food, Drug, and Cosmetic Act to require infant formula manufacturers to regularly test both their facilities and finished products for specified harmful microbes, including clostridium botulinum. If a test is positive, the company must notify the FDA within one business day, and the agency must inform the relevant House and Senate committees the next business day. The changes are intended to strengthen oversight and protect infants from contaminated formula.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HR 7867 changes status, plus AI-powered summaries and stage predictions.
Sign up free